Compare Revvity Inc (RVTY) vs SoFi Technologies Inc (SOFI) Price & Performance

RVTY trades at $115.18, down 0.72% on the day, with a bullish technical signal from moving averages and neutral oscillators. The company reported strong Q2 2026 earnings of $1.41 per share, beating estimates, and raised its full-year outlook, driven by diagnostics strength and AI-enabled drug discovery. Revenue for 2025 was $2.86 billion with a net income margin of 8.16%, though valuation ratios like P/E of 55.64 appear elevated. Recent news includes product launches like the SuperFlex prenatal system and presentations at investor conferences.

The outlook is positive with analyst consensus favoring a buy rating and a $120.50 price target, suggesting upside. Key opportunities include robust diagnostics demand and innovation pipelines, while risks involve high valuation multiples and competitive pressures in the healthcare sector. Cash flow improved in 2026 to a net positive $31 million, supporting growth initiatives.

SOFI trades at $18.12, down 1.41% today, with a bullish technical signal and recent earnings beats. Revenue grew to $3.61B in 2025, with a net income margin of 14.78%. The stock is supported by strong member growth and a consensus price target of $19.50, though negative operating cash flow and high valuation ratios present challenges.

Outlook is cautiously optimistic with growth potential from digital banking expansion, but risks include persistent negative cash flow, competitive pressures, and sensitivity to interest rate changes. Analyst sentiment is mixed, with 33% buy ratings highlighting upside, while high P/E of 36.69 warrants caution for value-focused investors.